MESO Q1 2017 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$395,000-94.7% YoY

Gross Profit

-$3M-734.2% margin

Operating Income

-$22M-5541.8% margin

Net Income

-$20M-5012.2% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

-98.5%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$847,000

Balance Sheet

Total Assets

$665M

Total Liabilities

$156M

Stockholders' Equity

$510M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$395,000	$8M	-94.7%
Gross Profit	-$3M	$1M	-321.4%
Operating Income	-$22M	-$14M	-51.3%
Net Income	-$20M	-$13M	-50.4%